Status report
Get it in writing
The official USPTO status record for TRUNEXUS, serial 88248211, as a dated PDF. One price, one document, delivered in about a minute.
INSTANT DELIVERY
Trademark Status Report
$7.99
The USPTO's own status record for this mark, on one dated page.
- Current status with a plain-English verdict
- Owner, classes, filing basis, and every key date
- The mark as it appears on the federal record
- Every prosecution event, filing to today
- Source-cited with the exact retrieval date
Built from the USPTO's TSDR record. Assignment chain of title and TTAB proceeding files sit in separate USPTO systems and are not included.
Preview
◆ TRADEMARKCHECKER.AITRADEMARK STATUS REPORT
TRUNEXUSSerial 88248211 · Principal Register
Dead · Refused
Owner: Elanco US Inc.
Class 005 - Pharmaceuticals
Filed Jan 03, 2019
The record shows that the application for “TRUNEXUS” filed by Elanco US Inc. on Jan 03 2019 is now dead; it was abandoned on Aug 08 2022 because no Statement of Use was filed after the Notice of Allowance. The goods listed are limited to class 005 pharmaceuticals for animals, including veterinary vaccines, antimicrobial preparations, reproductive enhancers, biopharmaceuticals, medicated feed, ectoparasiticides, insecticides, parasiticides, and hormone preparations. A similar name used in the same animal‑health space would be the closest record‑based concern, while uses outside those veterinary pharmaceutical categories fall farther from the scope shown. The prosecution history records multiple extensions of time to file a Statement of Use, but none resulted in a registration, and the mark never entered the Supplemental Register. The latest meaningful event is the abandonment notice on Aug 08 2022, and the supplied history shows no oppositions, cancellations or other enforcement actions. I'd treat this as a notable concern if you plan a comparable name in animal‑health products.
Full event history, owner details, and verdict inside.
The way I'd use it, honestly, is as the thing you attach when a bank, a marketplace, or a co-founder asks "are we clear on the name". It answers in one page.